Evidence map›Paper›PMID 25687358›Full record

ArticleAmerican journal of infection control2015

Prevalence and risk factors for methicillin-resistant Staphylococcus aureus in an HIV-positive cohort.

Jason E Farley, Matthew J Hayat, Paul L Sacamano, Tracy Ross, Karen Carroll

Open access · greenAbstract read
In one paragraph

Article in American journal of infection control, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Risk factors for methicillin-resistantThe Journal of international medical research · 2022
    Pooled it
  3. Trial
  4. A promisingClinical and experimental vaccine research · 2025
    Review
  5. Risk factors of methicillin-resistantFrontiers in microbiology · 2025
    Article
  6. Article
  7. Methicillin-resistantFuture science OA · 2022
    Article
  8. Article
  9. Article
  10. Methicillin-Resistant Coagulase-NegativeThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jason E FarleyDepartment of Community and Public Health, Johns Hopkins University School of Nursing, Baltimore, MD. Electronic address: Jfarley1@jhu.edu.
Matthew J HayatDepartments of Epidemiology and Biostatistics, School of Public Health, Georgia State University, Atlanta, GA.
Paul L SacamanoDepartment of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.
Tracy RossDepartment of Medical Microbiology, Johns Hopkins University School of Medicine, Baltimore, MD.
Karen CarrollDepartment of Medical Microbiology, Johns Hopkins University School of Medicine, Baltimore, MD.
Johns Hopkins University · USGeorgia State University · US

Funding

Institute for Clinical and Translational ResearchUL1TR001079 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2013 to 2017
$60.1M
NIDA Epidemiology Training Program: Johns Hopkins UniversityT32DA007292 · NIDA · JOHNS HOPKINS UNIVERSITY · PI RENEE M. JOHNSON, Brion S Maher · 1993 to 2026
$17.7M
Johns Hopkins HIV Epidemiology and Prevention Sciences Training ProgramT32AI102623 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Shruti H Mehta · 2013 to 2026
$5.3M
A Nurse Case Management Intervention to Improve MDR-TB/HIV Coinfection OutcomesR01AI104488 · NIAID · JOHNS HOPKINS UNIVERSITY · PI FARLEY, JASON EDWARD · 2014 to 2019
$3.2M
NCATS NIH HHS UL1 TR 001079NIAID NIH HHS R01 AI104488NIAID NIH HHS T32 AI102623NIDA NIH HHS T32 DA007292
6 · The paper itself

Abstract

backgroundPersons living with HIV (PLWH) are disproportionately burdened with methicillin-resistant Staphylococcus aureus (MRSA). Our objective was to evaluate prevalence and risks for MRSA colonization in PLWH.

methodsAdults were recruited from Johns Hopkins University AIDS Service in Baltimore, Maryland. A risk questionnaire and specimen collection from anatomic sites with culture susceptibility and genotyping were completed. Generalized estimating equation modeling identified MRSA colonization risk factors.

resultsOf 500 participants, most were black (69%), on antiretroviral therapy (ART) (87%), with undetectable viral loads (73.4%). Median CD4 count was 487 cells/mm(3) (interquartile range, 316-676.5 cells/mm(3)). MRSA prevalence was 15.4%, predominantly from the nares (59.7%). Forty percent were nares negative but were colonized elsewhere. Lower odds for colonization were associated with recent sexual activity (adjusted odds ratio [AOR] = 0.84, P < .001) and ART (AOR = 0.85, P = .011). Increased odds were associated with lower income (<$25,000 vs >$75,000; AOR = 2.68, P < .001), recent hospitalization (AOR = 1.54, P < .001), incarceration (AOR = 1.55, P < .001), use of street drugs (AOR = 1.43, P < .001), and skin abscess (AOR = 1.19, P < .001).

conclusionsEven with high MRSA prevalence, the proportion identified through nares surveillance alone was low, indicating the importance of screening multiple anatomic sites. Associations were not found with same-sex coupling or black race. MRSA prevention might be a benefit of ART in PLWH.

Indexed as

AdultAnti-Retroviral AgentsAntiretroviral Therapy, Highly ActiveBaltimoreCD4 Lymphocyte CountCohort StudiesCross-Sectional StudiesFemaleHIV InfectionsHospitalizationHumansMaleMethicillin-Resistant Staphylococcus aureusNosePrevalenceRisk FactorsAnti-Retroviral AgentsAnatomic siteHIVMethicillin-resistant Staphylococcus aureusPrevalenceRisk

Identifiers

PMID25687358
PMCPMC4386874
OpenAlexW1974367655

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.